Top Healthcare Stock Losers were GNVC, PIP, KERX

To get free alerts on Top Stocks, subscribe to Stock Markets Alerts by visiting:  http://www.pennystockpickreport.com/

GenVec, Inc. (NASDAQ:GNVC) declined 8.64% to $0.950 on 2.77 million shares. The stock is up over 216% from its 52-week low and has a market capitalization of $101.03 million. In the last six months the stock went down over 8%. GenVec, Inc. is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer.

PharmAthene, Inc. (AMEX:PIP) was down 9.03% to $1.41 on 1.76 million shares. The stock is up over 25% from its 52-week low and has a market capitalization of $40.10 million. In the last six months the stock went down over 35%. PharmAthene, Inc. formerly Healthcare Acquisition Corp., is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical weapons.

Keryx Biopharmaceuticals (NASDAQ:KERX) plunged 6.67% to $2.80 on 2.12 milion shares. The stock is up over 3011% from its 52-week low and has a market capitalization of $156.74 million. In the last six months the stock went up over 124%. Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of pharmaceutical products for the treatment of life-threatening including renal disease and cancer.